Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 9, Issue 7 (2020)

Analysis of vaccines to tackle Covid-19 with patent review

Divyansh Sehgal
As humans are spreading throughout the world, infectious diseases have been a constant companion such as Bubonic Plague (200 Million deaths), 17th Century Great Plague (3 Million deaths), Plague of Justinian (30-50 Million deaths), etc. Coronavirus Disease (COVID-19) which was published on 11th January 2020 showing the intensity of Global research and development activity to develop a drug/vaccine against the disease. COVID-19 is an infectious disease caused by a newly discovered coronavirus. Human to human transmission has created a pandemic situation across the world. Pharmaceutical companies play a crucial role in this scenario to provide Drugs/Vaccines/Therapies to treat and tackle the novel coronavirus disease of 2019. This paper consists of the Drugs and Vaccines which are developed, or in the process of development, their current stage of development (clinical trials) with their patent review.
Pages: 498-513  |  620 Views  112 Downloads

The Pharma Innovation Journal
How to cite this article:
Divyansh Sehgal. Analysis of vaccines to tackle Covid-19 with patent review. Pharma Innovation 2020;9(7):498-513. DOI: 10.22271/tpi.2020.v9.i7h.4983

Call for book chapter